NCT00996892View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors

PHASE1TerminatedINTERVENTIONAL

Enrollment

178

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Solid Tumors

Interventions

DRUG

Cobimetinib

Repeated oral dosing.

DRUG

Pictilisib

Repeated oral dosing.

Trial Locations (6)

21231

Baltimore

37203

Nashville

48201

Detroit

73104

Oklahoma City

02114

Boston

02215

Boston

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY